MER and other mycobacterial fractions in the immunotherapy of cancer.
D000818:Animals; D000917:Antibody Formation; D000942:Antigens, Bacterial / Q000494:pharmacology; D001500:BCG Vaccine / Q000627:therapeutic use*; D006801:Humans; D007111:Immunity, Cellular; D007115:Immunization Schedule; D008213:Lymphocyte Activation; D009161:Mycobacterium / Q000276:immunology*; D009369:Neoplasms / Q000276:immunology / Q000401:mortality / Q000628:therapy*; D009374:Neoplasms, Experimental / Q000276:immunology; D014613:Vaccines, Attenuated / Q000494:pharmacology*
D000942:Antigens, Bacterial; D001500:BCG Vaccine; D014613:Vaccines, Attenuated